Ortin Historical Income Statement

ORTINLAB

19.63 0.00 0.00%

Historical analysis of Ortin Laboratories income statement accounts such as Other Operating Expenses of 84.3 M can show how well Ortin Laboratories Limited performed in making a profits. Evaluating Ortin Laboratories income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Ortin Laboratories's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Ortin Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ortin Laboratories is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Ortin Income Statement Analysis

Ortin Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Ortin Laboratories shareholders. The income statement also shows Ortin investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Ortin Laboratories Income Statement Chart

At present, Ortin Laboratories' Total Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 10.1 M, whereas Depreciation And Amortization is forecasted to decline to about 2.2 M.

Total Revenue Other Operating Expenses Cost Of Revenue Selling General Administrative

Total Revenue

Total revenue comprises all receipts Ortin Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Ortin Laboratories. It is also known as Ortin Laboratories overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Ortin Laboratories income statement and represents the costs associated with goods and services Ortin Laboratories provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Ortin Laboratories' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Ortin Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Interest Expense	7.9M	4.0M	4.8M	4.6M
Depreciation And Amortization	2.9M	2.5M	2.3M	2.2M

Interest Expense Depreciation And Amortization

Ortin Laboratories income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Selling And Marketing Expenses	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.92	0.73	0.51	0.7	0.67	0.75	0.82	0.77	0.27	0.59	-0.96	0.5	0.24	-0.14	0.42	0.45	-0.82	0.82	0.36	0.85
Interest Expense	0.92		0.51	0.29	0.47	0.58	0.8	0.85	0.55	0.02	0.62	-0.99	0.54	0.23	-0.26	0.19	0.21	-0.8	0.74	0.43	0.78
Total Revenue	0.73	0.51		0.9	1.0	0.67	0.51	0.56	0.99	0.78	0.45	-0.62	0.35	0.25	0.1	0.86	0.65	-0.57	0.64	0.22	0.68
Gross Profit	0.51	0.29	0.9		0.91	0.64	0.37	0.41	0.85	0.94	0.38	-0.4	0.31	0.12	0.1	0.77	0.55	-0.37	0.45	0.1	0.48
Other Operating Expenses	0.7	0.47	1.0	0.91		0.63	0.46	0.51	0.99	0.81	0.4	-0.58	0.3	0.26	0.1	0.87	0.67	-0.53	0.61	0.2	0.65
Operating Income	0.67	0.58	0.67	0.64	0.63		0.9	0.89	0.66	0.35	0.93	-0.66	0.92	-0.24	0.21	0.5	0.19	-0.71	0.62	0.47	0.73
Ebit	0.75	0.8	0.51	0.37	0.46	0.9		0.99	0.53	0.02	0.97	-0.82	0.93	-0.07	0.11	0.3	0.12	-0.84	0.72	0.51	0.81
Ebitda	0.82	0.85	0.56	0.41	0.51	0.89	0.99		0.59	0.06	0.94	-0.87	0.89	-0.02	0.07	0.33	0.17	-0.86	0.76	0.5	0.85
Cost Of Revenue	0.77	0.55	0.99	0.85	0.99	0.66	0.53	0.59		0.72	0.45	-0.65	0.35	0.28	0.1	0.86	0.66	-0.6	0.67	0.25	0.71
Total Operating Expenses	0.27	0.02	0.78	0.94	0.81	0.35	0.02	0.06	0.72		0.04	-0.12	-0.02	0.17	0.07	0.72	0.56	-0.09	0.21	-0.08	0.21
Income Before Tax	0.59	0.62	0.45	0.38	0.4	0.93	0.97	0.94	0.45	0.04		-0.65	0.98	-0.19	0.25	0.3	0.05	-0.75	0.63	0.48	0.73
Total Other Income Expense Net	-0.96	-0.99	-0.62	-0.4	-0.58	-0.66	-0.82	-0.87	-0.65	-0.12	-0.65		-0.57	-0.21	0.21	-0.3	-0.3	0.82	-0.78	-0.41	-0.83
Net Income	0.5	0.54	0.35	0.31	0.3	0.92	0.93	0.89	0.35	-0.02	0.98	-0.57		-0.36	0.22	0.23	-0.07	-0.66	0.51	0.5	0.62
Income Tax Expense	0.24	0.23	0.25	0.12	0.26	-0.24	-0.07	-0.02	0.28	0.17	-0.19	-0.21	-0.36		0.12	0.2	0.66	-0.27	0.49	-0.36	0.33
Selling General Administrative	-0.14	-0.26	0.1	0.1	0.1	0.21	0.11	0.07	0.1	0.07	0.25	0.21	0.22	0.12		0.18	0.17	-0.36	0.36	0.13	0.36
Selling And Marketing Expenses	0.42	0.19	0.86	0.77	0.87	0.5	0.3	0.33	0.86	0.72	0.3	-0.3	0.23	0.2	0.18		0.67	-0.28	0.39	-0.03	0.42
Tax Provision	0.45	0.21	0.65	0.55	0.67	0.19	0.12	0.17	0.66	0.56	0.05	-0.3	-0.07	0.66	0.17	0.67		-0.3	0.59	-0.49	0.44
Net Interest Income	-0.82	-0.8	-0.57	-0.37	-0.53	-0.71	-0.84	-0.86	-0.6	-0.09	-0.75	0.82	-0.66	-0.27	-0.36	-0.28	-0.3		-0.93	-0.5	-0.98
Interest Income	0.82	0.74	0.64	0.45	0.61	0.62	0.72	0.76	0.67	0.21	0.63	-0.78	0.51	0.49	0.36	0.39	0.59	-0.93		0.22	0.96
Net Income From Continuing Ops	0.36	0.43	0.22	0.1	0.2	0.47	0.51	0.5	0.25	-0.08	0.48	-0.41	0.5	-0.36	0.13	-0.03	-0.49	-0.5	0.22		0.44
Reconciled Depreciation	0.85	0.78	0.68	0.48	0.65	0.73	0.81	0.85	0.71	0.21	0.73	-0.83	0.62	0.33	0.36	0.42	0.44	-0.98	0.96	0.44

Click cells to compare fundamentals

Ortin Laboratories Account Relationship Matchups

Ortin Laboratories income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	19.6M	2.9M	2.9M	2.5M	2.3M	2.2M
Interest Expense	24.7M	8.7M	7.9M	4.0M	4.8M	4.6M
Total Revenue	2.0B	81.7M	82.3M	60.2M	21.1M	20.1M
Gross Profit	359.4M	42.0M	35.8M	26.3M	(23.9M)	(22.7M)
Other Operating Expenses	1.9B	72.1M	79.8M	57.1M	88.8M	84.3M
Operating Income	38.0M	9.6M	3.2M	2.7M	(67.7M)	(64.3M)
Ebit	32.0M	10.1M	2.6M	2.9M	(67.7M)	(64.3M)
Ebitda	51.5M	13.0M	5.5M	5.4M	(65.4M)	(62.1M)
Cost Of Revenue	1.6B	39.7M	46.5M	33.9M	45.1M	42.8M
Total Operating Expenses	321.9M	32.4M	33.3M	23.2M	43.7M	60.0M
Income Before Tax	7.2M	1.4M	(5.3M)	(838K)	(70.8M)	(67.2M)
Total Other Income Expense Net	(30.8M)	(8.2M)	(7.8M)	(4.2M)	(3.1M)	(3.3M)
Net Income	(5.6M)	9.5M	(4.0M)	(669K)	(80.4M)	(76.4M)
Income Tax Expense	12.8M	(8.1M)	(1.3M)	(169K)	9.7M	10.1M
Selling General Administrative	7.5M	1.5M	1.4M	1.8M	1.6M	1.5M
Selling And Marketing Expenses	21.8M	4.3M	5.9M	1.3M	1.5M	1.4M
Tax Provision	12.8M	(8.1M)	(1.3M)	(169K)	(152.1K)	(144.5K)
Net Interest Income	(30.6M)	(8.7M)	(8.1M)	(4.0M)	(4.6M)	(4.8M)
Interest Income	1.5M	496.0	32.9K	196K	176.4K	167.6K
Net Income From Continuing Ops	(5.6M)	9.5M	(4.0M)	(669K)	(602.1K)	(572.0K)
Reconciled Depreciation	19.6M	2.9M	2.9M	2.5M	2.3M	2.1M
Net Income Applicable To Common Shares	(5.6M)	9.5M	(4.0M)	(936K)	(842.4K)	(800.3K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Ortin Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ortin Historical Income Statement

About Ortin Income Statement Analysis

Ortin Laboratories Income Statement Chart

Total Revenue

Other Operating Expenses

Cost Of Revenue

Ortin Laboratories income statement Correlations

Ortin Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ortin Laboratories income statement Accounts

Also Currently Popular

Other Information on Investing in Ortin Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Other Operating Expenses
Ebitda	+ 0.99	Ebit
Net Income	+ 0.98	Income Before Tax
Income Before Tax	+ 0.97	Ebit

Total Other Income Expense Net	- 0.99	Interest Expense
Reconciled Depreciation	- 0.98	Net Interest Income
Total Other Income Expense Net	- 0.96	Depreciation And Amortization
Interest Income	- 0.93	Net Interest Income
Total Other Income Expense Net	- 0.87	Ebitda
Net Interest Income	- 0.86	Ebitda